| Identification | |
| Name: | Acrivastine |
| Synonyms: | 2-Propenoicacid, 3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-,(2E)- (9CI);2-Propenoic acid,3-[6-[1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-, (E,E)-;BW 0270C;BW 825C;BW A825C;Semprex; |
| CAS: | 87848-99-5 |
| Molecular Formula: | C22H24N2O2 |
| Molecular Weight: | 348.44 |
| InChI: | InChI=1/C22H24N2O2/c1-17-7-9-18(10-8-17)20(13-16-24-14-2-3-15-24)21-6-4-5-19(23-21)11-12-22(25)26/h4-13H,2-3,14-16H2,1H3,(H,25,26)/b12-11+,20-13+ |
| Molecular Structure: | ![(C22H24N2O2) 2-Propenoicacid, 3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-,(2E)- (9...](https://img1.guidechem.com/chem/e/dict/40/87848-99-5.jpg) |
| Properties | |
| Density: | 1.17 g/cm3 |
| Stability: | Stable at normal temperatures and pressures. |
| Refractive index: | 1.627 |
| Solubility: | Insoluble |
| Specification: |
Acrivastine , its cas register number is 87848-99-5. It also can be called Semprex-D ; (E)-6-((E)-3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)-2-pyridineacrylic acid ; (E)-6-((E)-3-(1-Pyrrolidinyl-1-p-tolylpropenyl)-2-pyridinacrylsaeure ; 2-Propenoic acid, 3-(6-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-2-pyridinyl)-, (E,E)- ; Acrivastin ; Acrivastina ; Acrivastinum ; Semprex . |
| Storage Temperature: | No storage requirements necessary for occupational hazards. Follow product information storage instructions to maintain efficacy. |
| Usage: | This material is a histamine antagonist (h1 sub-type). It is an agent intended for the treatment of allergic rhinitis. |
| Safety Data | |
 |
|
